KMB vs QNRX · P/E 19, rev $8.35B vs $9.6M cap
Kimberly-Clark Corporation (KMB) versus Quoin Pharmaceuticals Ltd DRC (QNRX) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Quoin Pharmaceuticals Ltd DRC (QNRX) is a biotechnology company listed on NASDAQ.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
QNRX does not have a complete income-statement cache yet.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. QNRX currently screens at market cap $9.6M.
Not investment advice. Open the KMB and QNRX stock pages for the full models.
Not investment advice.